Oxford BioTherapeutics
CA - San JoseBiotechnology
Focus: Oxford BioTherapeutics is a San Jose-based biotechnology company specializing in antibody therapies, with a focus on oncology applications. The company operates at pre-revenue/early-stage biotech scale with a lean workforce and multiple early-phase pipeline programs.
Profile data last refreshed 12h ago · AI intelligence enriched 3w ago
Open Jobs
6
Should You Work at Oxford BioTherapeutics?
AI assessmentBest suited for early-stage scientists and engineers willing to accept pre-revenue risk in exchange for platform-level autonomy and BMS partnership validation.
Why Work Here
- Recent high-profile partnership with Bristol Myers Squibb (April 2026) on T-cell engager discovery validates platform technology and signals access to Big Pharma resources and distribution.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
MVA-NP+M1
Human VolunteersOBT076, a CD205-directed antibody-drug conjugate
Solid TumorEnadenotucirev
Help build intelligence for Oxford BioTherapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.